Title : Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.

Pub. Date : 2020 Nov 30

PMID : 33266022






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: High-dose vitamin D treatment alone and combined with infliximab decreased the IL17A, IFNgamma and IL10 expression. Vitamin D interleukin 17A Homo sapiens
2 CONCLUSIONS: High-dose vitamin D as monotherapy and combined with infliximab decreases IL17A, IFNgamma and IL-10 expression in mucosa within treatment groups. Vitamin D interleukin 17A Homo sapiens